Stock Analysis on Net
Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

Common-Size Balance Sheet: Assets

Abbott Laboratories, common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash and cash equivalents 9.42 13.28 13.03 9.43 5.69
Investments, primarily bank time deposits and U.S. treasury bills 0.52 0.39 0.60 0.43 0.41
Trade receivables, less allowances 8.97 8.35 8.63 8.84 7.99
Inventories 8.97 8.29 6.86 6.91 6.36
Other prepaid expenses and receivables 3.08 3.58 3.12 2.57 2.63
Current assets 30.96% 33.89% 32.23% 28.18% 23.08%
Equity securities 0.76 0.75 0.99 1.07 1.23
Other 0.33 0.28 0.09 0.06 0.07
Long-term investments 1.09% 1.03% 1.09% 1.13% 1.30%
Net property and equipment 13.87 12.31 11.91 12.45 11.84
Intangible assets, net of amortization 12.04 14.04 16.94 20.38 25.08
Goodwill 32.34 30.63 30.89 32.73 34.17
Deferred income taxes and other assets 9.69 8.10 6.93 5.14 4.54
Long-term assets 69.04% 66.11% 67.77% 71.82% 76.92%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Abbott Laboratories current assets as a percentage of total assets increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Net property and equipment Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Abbott Laboratories net property and equipment as a percentage of total assets increased from 2021 to 2022 and from 2022 to 2023.
Long-term assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Abbott Laboratories long-term assets as a percentage of total assets decreased from 2021 to 2022 but then increased from 2022 to 2023 exceeding 2021 level.